WASHINGTON — President Trump is trying to do what President Obama failed to accomplish: stand up to the pharmaceutical industry and doctors to change the way that the government pays for drugs.
In a sweeping proposal Thursday that lacked critical details, his Department of Health and Human Services detailed a plan to change the way that Medicare pays for doctor-administered drugs in the Part B program, with one goal of removing the current incentive for doctors to prescribe high-cost drugs. The end goal: to bring down costs for the government and ultimately, for patients.
